| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Davis Advisors | 0.04% | 964,486 | TRIMMED (-5.6%) |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 14 sales by 1 insiders ($126.2K).
Source: SEC Form 4 filings, as of Oct 3, 2026. Open-market transactions only.
Data unavailable — no House STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).
Financial Screens
· Graham — Sound finances and a long run of profits
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
· Shareholder Yield — Cash returned through dividends and buybacks
· Net-Net (NCAV) — Market cap below net current asset value
Key figures
· Graham — Current ratio: 4.46 · Straight profitable years: 5 · Debt ratio: 0.18 · Latest net income: $79.9M
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.29 · Operating cash flow: $139.7M · Net income: $79.9M
· Shareholder Yield — Shareholder yield: 3.1% · of which dividends: 2.9% · of which buybacks: 0.3%
· Net-Net (NCAV) — NCAV: $4.6B · Market cap: $2.7B · NCAV / market cap: 1.68
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.